{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:45:04Z","timestamp":1791830704163,"version":"4.3.4"},"reference-count":190,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00002","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T23:14:03Z","timestamp":1516144443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":318,"title":["Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links"],"prefix":"10.3389","volume":"9","author":[{"given":"Salvatore","family":"De Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Arcidiacono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eusebio","family":"Chiefari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"9467","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.10.2569-a","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp068177","article-title":"Obesity and diabetes in the developing world \u2013 a growing challenge","volume":"356","author":"Hossain","year":"2007","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0889-8529(05)70322-4","article-title":"Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs","volume":"2","author":"Krolewski","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics-2017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/01.CIR.100.10.1134","article-title":"Diabetes and cardiovascular disease: a statement for health professionals from the American Heart Association","volume":"100","author":"Grundy","year":"1999","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1161\/01.ATV.0000164044.42910.6b","article-title":"The union of vascular and metabolic actions of insulin in sickness and in health","volume":"25","author":"Kim","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0026-895X(24)23187-4","article-title":"Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme","volume":"55","author":"Woods","year":"1999","journal-title":"Mol Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes","volume":"350","author":"Petersen","year":"2004","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus \u2013 mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J Diabetes Complications"},{"key":"B14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2013 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1001\/jama.263.21.2893","article-title":"Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1089\/ars.2010.3739","article-title":"Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome","volume":"15","author":"Otani","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1161\/01.CIR.0000160361.73423.23","article-title":"Atherothrombotic disorders: new insights from hematology","volume":"111","author":"Andreotti","year":"2005","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1161\/01.HYP.37.4.1053","article-title":"Diabetes, hypertension, and cardiovascular disease: an update","volume":"37","author":"Sowers","year":"2001","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/diabetes.44.4.369","article-title":"Diabetes and cardiovascular disease. The \u201ccommon soil\u201d hypothesis","volume":"44","author":"Stern","year":"1995","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.metabol.2014.08.010","article-title":"Diabetic dyslipidemia","volume":"63","author":"Wu","year":"2014","journal-title":"Metabolism"},{"key":"B22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1076-7460.2002.00998.x","article-title":"Obesity, diabetes, and risk of cardiovascular disease in the elderly","volume":"11","author":"Wilson","year":"2002","journal-title":"Am J Geriatr Cardiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jacc.2011.08.080","article-title":"Pre-diabetes, metabolic syndrome, and cardiovascular risk","volume":"59","author":"Grundy","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"750860","DOI":"10.1155\/2014\/750860","article-title":"Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals","volume":"2014","author":"Greco","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jdi.12391","article-title":"Genetics of cardiovascular and renal complications in diabetes","volume":"7","author":"Ma","year":"2016","journal-title":"J Diabetes Investig"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jama.2011.207","article-title":"Functional variants of the HMGA1 gene and type 2 diabetes mellitus","volume":"305","author":"Chiefari","year":"2011","journal-title":"JAMA"},{"key":"B27","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijcard.2016.11.088","article-title":"HMGA1 is a novel candidate gene for myocardial infarction susceptibility","volume":"227","author":"De Rosa","year":"2017","journal-title":"Int J Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1253\/circj.CJ-14-0086","article-title":"Emerging role of microRNAs in cardiovascular diseases","volume":"78","author":"De Rosa","year":"2014","journal-title":"Circ J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/CIRCRESAHA.115.308237","article-title":"MicroRNAs for restenosis and thrombosis after vascular injury","volume":"118","author":"Gareri","year":"2016","journal-title":"Circ Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"19987","DOI":"10.3390\/ijms141019987","article-title":"Non-coding RNAs: the \"dark matter\" of cardiovascular pathophysiology","volume":"14","author":"Iaconetti","year":"2013","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.2337\/dc17-S005","article-title":"Standards of medical care in diabetes-2017, classification and diagnosis of diabetes","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1056\/NEJMra1105239","article-title":"Genomics of cardiovascular disease","volume":"365","author":"O\u2019Donnell","year":"2011","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1093\/hmg\/ddn275","article-title":"Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants","volume":"17","author":"Mohlke","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1016\/j.cell.2012.03.001","article-title":"Genetics of human cardiovascular disease","volume":"148","author":"Kathiresan","year":"2012","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/1753-0407.12323","article-title":"Genetic markers of type 2 diabetes: progress in genome-wide association studies and clinical application for risk prediction","volume":"8","author":"Wang","year":"2016","journal-title":"J Diabetes"},{"key":"B37","first-page":"316","article-title":"Genomics of complex cardiovascular disease","volume-title":"Genomic Medicine: Principles and Practice","author":"Ashar","year":"2014"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.2337\/diacare.27.8.2015","article-title":"The +276 G\/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients","volume":"27","author":"Bacci","year":"2004","journal-title":"Diabetes Care"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.2337\/db06-0613","article-title":"Common haplotypes at the adiponectin receptor 1 (ADIPOR1) locus are associated with increased risk of coronary artery disease in type 2 diabetes","volume":"55","author":"Soccio","year":"2006","journal-title":"Diabetes"},{"key":"B40","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1900\/RDS.2011.8.230","article-title":"Association between genetics of diabetes, coronary artery disease, and macrovascular complications: exploring a common ground hypothesis","volume":"8","author":"Sousa","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0021-9150(93)90096-D","article-title":"Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insuli dependent diabetes mellitus","volume":"101","author":"Ukkola","year":"1993","journal-title":"Atherosclerosis"},{"key":"B42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-016-0329-1","article-title":"Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease","volume":"15","author":"El-Lebedy","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1016\/j.jacc.2011.08.054","article-title":"Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies","volume":"58","author":"Qi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jama.2013.276305","article-title":"Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes","volume":"310","author":"Qi","year":"2013","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12933-016-0435-0","article-title":"Variant rs10911021 that associates with coronary heart disease in type 2 diabetes, is associated with lower concentrations of circulating HDL cholesterol and large HDL particle but not with amino acids","volume":"15","author":"Beaney","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B46","first-page":"308","article-title":"Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease","volume":"6","author":"Levy","year":"2004","journal-title":"Isr Med Assoc J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1475-2840-12-31","article-title":"Genetic analysis of haptoglobin polymorphisms with cardiovascular disease and type 2 diabetes in the diabetes heart study","volume":"12","author":"Adams","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(95)92709-3","article-title":"Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes","volume":"346","author":"Ruiz","year":"1995","journal-title":"Lancet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"30005","DOI":"10.1172\/JCI118373","article-title":"A variant of human paraoxonase\/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease","volume":"96","author":"Serrato","year":"1995","journal-title":"J Clin Invest"},{"key":"B50","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1172\/JCI119134","article-title":"Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentration of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease","volume":"99","author":"Blatter Garin","year":"1997","journal-title":"J Clin Invest"},{"key":"B51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2337\/diabetes.48.3.623","article-title":"Paraoxonase 192 Gln\/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes","volume":"48","author":"Pfohl","year":"1999","journal-title":"Diabetes"},{"key":"B52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.diabres.2010.07.009","article-title":"Association between the rs4880 superoxide dismutase 2(C>T) gene variant and coronary heart disease in diabetes mellitus","volume":"90","author":"Jones","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e7697","DOI":"10.1371\/journal.pone.0007697","article-title":"TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality","volume":"11","author":"Sousa","year":"2009","journal-title":"PLoS One"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e17978","DOI":"10.1371\/journal.pone.0017978","article-title":"Single nucleotide polymorphisms of TCF7L2 are linked to diabetic coronary atherosclerosis","volume":"3","author":"Muendlein","year":"2011","journal-title":"PLoS One"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1253\/circj.CJ-09-0057","article-title":"Adiponectin and cardiovascular disease","volume":"74","author":"Shibata","year":"2009","journal-title":"Circ J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"534","DOI":"10.2337\/diabetes.54.2.534","article-title":"Adiponectin and future coronary heart disease events among men with type 2 diabetes","volume":"54","author":"Schulze","year":"2005","journal-title":"Diabetes"},{"key":"B58","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction","volume":"316","author":"Helgadottir","year":"2007","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.1142358","article-title":"Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels","volume":"316","author":"Saxena","year":"2007","journal-title":"Science"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1126\/science.1142382","article-title":"A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants","volume":"316","author":"Scott","year":"2007","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.1142364","article-title":"Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes","volume":"316","author":"Zeggini","year":"2007","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1007\/s13277-016-4808-5","article-title":"ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/520599","article-title":"Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium","volume":"81","author":"Salonen","year":"2007","journal-title":"Am J Hum Genet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/hmg\/ddm352","article-title":"Susceptibility to coronary heart disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p","volume":"17","author":"Broadbent","year":"2008","journal-title":"Hum Mol Genet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nature08801","article-title":"Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice","volume":"464","author":"Visel","year":"2010","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e1000899","DOI":"10.1371\/journal.pgen.1000899","article-title":"Chromosome 9p21 SNPs associated with multiple disease phenotypes correlate with ANRIL expression","volume":"6","author":"Cunnington","year":"2010","journal-title":"PLoS Genet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature09753","article-title":"9p21 DNA variants associated with coronary artery disease impair interferon-\u03b3 signalling response","volume":"470","author":"Harismendy","year":"2011","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/ATVBAHA.109.189522","article-title":"Functional analysis of the chromosome 9p21.3 coronary artery diseaes risk locus","volume":"29","author":"Jarinova","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.2337\/db13-1921","article-title":"Cdkn2a\/p16Ink4a regulates fasting-induced hepatic gluconeogenesis through the PKA-CREB-PGC1\u03b1 pathway","volume":"63","author":"Bantubungi","year":"2014","journal-title":"Diabetes"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e1003588","DOI":"10.1371\/journal.pgen.1003588","article-title":"Alu elements in ANRIL non-coding RNA at chromosome 9p21 modulate atherogenic cell functions through trans-regulation of gene networks","volume":"9","author":"Holdt","year":"2013","journal-title":"PLoS Genet"},{"key":"B73","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"B74","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00125-008-1004-1","article-title":"TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the atherosclerosis risk in communities (ARIC) study","volume":"6","author":"Bielinski","year":"2008","journal-title":"Diabetologia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0021-9150(02)00429-X","article-title":"A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart diseaes in type 2 diabetic patients","volume":"167","author":"Vendrell","year":"2003","journal-title":"Atherosclerosis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1161\/01.RES.0000076889.23082.F1","article-title":"Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease","volume":"92","author":"Asleh","year":"2003","journal-title":"Circ Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nrendo.2013.192","article-title":"Diabetes: unravelling the enigma of type 2 DM and cardiovascular disease","volume":"9","author":"Bowden","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCGENETICS.114.000676","article-title":"Shared molecular pathways and gene networks for cardiovascular disease and type 2 diabetes mellitus in women across diverse ethnicities","volume":"7","author":"Chan","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"737","DOI":"10.2337\/dc12-0852","article-title":"Diabetes genetic predisposition score and cardiovascular complications among patients with type 2 diabetes","volume":"36","author":"Qi","year":"2013","journal-title":"Diabetes Care"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1007\/s00125-011-2206-5","article-title":"Individual and cumulative effect of type 2 diabetes genetic susceptibility variants on risk of coronary heart disease","volume":"54","author":"Pfister","year":"2011","journal-title":"Diabetologia"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2337\/dc13-1514","article-title":"Genetic risk score associations with cardiovascular disease and mortality in the diabetes heart study","volume":"37","author":"Cox","year":"2014","journal-title":"Diabetes Care"},{"key":"B82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0378-1119(01)00689-8","article-title":"Molecular biology of HMGA proteins: hubs of nuclear function","volume":"277","author":"Reeves","year":"2001","journal-title":"Gene"},{"key":"B83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbagrm.2009.08.009","article-title":"HMGA molecular network: from transcriptional regulation to chromatin remodeling","volume":"1799","author":"Sgarra","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B84","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1186\/1471-2164-12-549","article-title":"HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis","volume":"12","author":"Schuldenfrei","year":"2011","journal-title":"BMC Genomics"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1093\/emboj\/18.11.3074","article-title":"The role of HMG I(Y) in the assembly and function of the IFN-beta enhanceosome","volume":"18","author":"Yie","year":"1999","journal-title":"EMBO J"},{"key":"B86","doi-asserted-by":"publisher","first-page":"8552","DOI":"10.1038\/srep08552","article-title":"A novel mechanism of post-translational modulation of HMGA1 functions by the histone chaperone nucleophosmin","volume":"5","author":"Arnoldo","year":"2015","journal-title":"Sci Rep"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.1158\/0008-5472.CAN-05-3678","article-title":"Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer","volume":"10","author":"Paonessa","year":"2006","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/MCB.23.8.2720-2732.2003","article-title":"A nucleoprotein complex containing Sp1, C\/EBP beta, and HMGI-Y controls human insulin receptor gene expression","volume":"23","author":"Foti","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1677\/ERC-07-0226","article-title":"The insulin receptor: a new nticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists","volume":"15","author":"Costa","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1210\/me.2011-1379","article-title":"The HMGA1-IGF-I\/IGFBP system: a novel pathway for modulating glucose uptake","volume":"6","author":"Iiritano","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1016\/j.biocel.2009.04.011","article-title":"Transcriptional activity of the murine retinol-binding protein gene is regulated by a multiprotein complex containing HMGA1, p54 nrb\/NonO, protein-associated splicing factor (PSF) and steroidogenic factor 1 (SF1)\/liver receptor homologue 1 (LHR-1)","volume":"41","author":"Bianconcini","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fendo2016.00073","article-title":"Cooperation between HMGA1 and HIF-1 contributes to hypoxia-induced VEGF and visfatin gene expression in 3T3-L1 adipocytes","volume":"7","author":"Messineo","year":"2016","journal-title":"Front Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fendo.2014.00237","article-title":"Cooperation between HMGA1, PDX-1, and MafA is essential for glucose-induced insulin transcription in pancreatic beta cells","volume":"5","author":"Arcidiacono","year":"2015","journal-title":"Front Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/srep00251","article-title":"HMGA1 is a novel downstream nuclear target of the insulin recptor signaling pathway","volume":"2","author":"Chiefari","year":"2012","journal-title":"Sci Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nm1254","article-title":"Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in human and mice","volume":"7","author":"Foti","year":"2005","journal-title":"Nat Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/ncomms1040","article-title":"Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes","volume":"1","author":"Chiefari","year":"2010","journal-title":"Nat Commun"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/met.2013.0086","article-title":"Evidence that an HMGA1 gene variant associates with type 2 diabetes, body mass index, and high-density lipoprotein cholesterol in a Hispanic-American population","volume":"12","author":"Pullinger","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"B98","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1371\/journal.pone.0136077","article-title":"The association between HMGA1 rs146052672 variant and type 2 diabetes: a transethnic meta-analysis","volume":"10","author":"Bianco","year":"2015","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/srep01491","article-title":"A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components","volume":"3","author":"Chiefari","year":"2013","journal-title":"Sci Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1128\/MCB.21.7.2485-2495.2001","article-title":"Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation","volume":"21","author":"Melillo","year":"2001","journal-title":"Mol Cell Biol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"14487","DOI":"10.1038\/srep14487","article-title":"HMGA1 overexpression in adiose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance","volume":"5","author":"Arce-Cerezo","year":"2015","journal-title":"Sci Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.onc.1207167","article-title":"High-mobility group A1a protein regulates Ras\/ERK signaling in MCF-7 human breast cancer cells","volume":"23","author":"Treff","year":"2004","journal-title":"Oncogene"},{"key":"B103","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1096\/fasebj.14.2.368","article-title":"Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells","volume":"14","author":"Foster","year":"2000","journal-title":"FASEB J"},{"key":"B104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.prp.2004.11.010","article-title":"HMGA1 proteins in human atherosclerotic plaques","volume":"201","author":"Schlueter","year":"2005","journal-title":"Pathol Res Pract"},{"key":"B105","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1161\/CIRCRESAHA.111.253658","article-title":"High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-gamma mediated transrepression in the vasculature","volume":"110","author":"Bloch","year":"2012","journal-title":"Circ Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"39429","DOI":"10.1038\/srep39429","article-title":"A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expression","volume":"6","author":"Chiefari","year":"2016","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2337\/diabetes.52.5.1256","article-title":"High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells","volume":"52","author":"Shanmugam","year":"2003","journal-title":"Diabetes"},{"key":"B108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/vph.2012.05.005","article-title":"The emerging challenge in diabetes: the \u201cmetabolic memory\u201d","volume":"57","author":"Ceriello","year":"2012","journal-title":"Vascul Pharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1101\/gr.116095.110","article-title":"Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells","volume":"21","author":"Pirola","year":"2011","journal-title":"Genome Res"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2337\/db08-1666","article-title":"Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail","volume":"58","author":"Brasacchio","year":"2009","journal-title":"Diabetes"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1161\/CIRCRESAHA.116.306819","article-title":"Epigenetic changes in diabetic and cardiovascular risk","volume":"118","author":"Keating","year":"2016","journal-title":"Circ Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.2337\/db12-1648","article-title":"SIRT1, p66(Shc), and Set7\/9 in vascular hyperglycemic memory: bringing all the strands together","volume":"62","author":"Paneni","year":"2013","journal-title":"Diabetes"},{"key":"B113","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.trsl.2014.04.004","article-title":"Clinical applications of epigenetics in cardiovascular disease: the long road ahead","volume":"165","author":"Aslibekyan","year":"2015","journal-title":"Transl Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13148-016-0293-3","article-title":"Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes","volume":"8","author":"Sathiskumar","year":"2016","journal-title":"Clin Epigenetics"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e14040","DOI":"10.1371\/journal.pone.0014040","article-title":"Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus","volume":"5","author":"Bell","year":"2010","journal-title":"PLoS One"},{"key":"B116","doi-asserted-by":"publisher","first-page":"e71901","DOI":"10.1371\/journal.pone.0071901","article-title":"The FTO gene rs9939609 polymorphism predict risk of cardiovascular disease: a systematic review and metanalysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"B117","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000351707","article-title":"IGF2 methylation is associated with lipid profile in obese children","volume":"79","author":"Deodati","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00125-016-4074-5","article-title":"The epigenetic signature of systemic insulin resistance in obese women","volume":"59","author":"Arner","year":"2016","journal-title":"Diabetologia"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.2337\/db13-1459","article-title":"Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes","volume":"63","author":"Nilsson","year":"2014","journal-title":"Diabetes"},{"key":"B120","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1093\/hmg\/ddv124","article-title":"Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood","volume":"24","author":"R\u00f6nn","year":"2015","journal-title":"Hum Mol Genet"},{"key":"B121","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13059-014-0569-x","article-title":"An analysis of DNAmethylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss","volume":"16","author":"Benton","year":"2015","journal-title":"Genome Biol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1210\/me.2013-1293","article-title":"Epigenetic regulation of macrophage polarization by DNAmethyltransferase 3b","volume":"28","author":"Yang","year":"2014","journal-title":"Mol Endocrinol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ije\/dyr153","article-title":"Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction","volume":"41","author":"Talens","year":"2012","journal-title":"Int J Epidemiol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"B125","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/jhg.2016.150","article-title":"Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus","volume":"62","author":"Hashimoto","year":"2017","journal-title":"J Hum Genet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1038\/emm.2016.7","article-title":"Recent progress in genetic and epigenetic research on type 2 diabetes","volume":"48","author":"Kwak","year":"2016","journal-title":"Exp Mol Med"},{"key":"B127","doi-asserted-by":"publisher","first-page":"4080364","DOI":"10.1155\/2017\/4080364","article-title":"MicroRNAs and cardiovascular disease in diabetes mellitus","volume":"2017","author":"Ding","year":"2017","journal-title":"Biomed Res Int"},{"key":"B128","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3892\/mmr.2011.489","article-title":"Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice","volume":"4","author":"Diao","year":"2011","journal-title":"Mol Med Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12933-016-0390-9","article-title":"Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells","volume":"15","author":"La Sala","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/jpet.115.226894","article-title":"Molecular interplay between microRNA-34a and sirtuin1 in hyperglycemia-mediated impaired angiogenesis in endothelial cells: effects of metformin","volume":"356","author":"Arunachalam","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"12565","DOI":"10.1038\/ncomms12565","article-title":"Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating sirtuin1","volume":"7","author":"Vikram","year":"2016","journal-title":"Nat Commun"},{"key":"B132","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis","volume":"15","author":"Wang","year":"2008","journal-title":"Dev Cell"},{"key":"B133","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity","volume":"15","author":"Fish","year":"2008","journal-title":"Dev Cell"},{"key":"B134","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci Signal"},{"key":"B135","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.vph.2016.12.002","article-title":"MicroRNA-126 suppresses inflammation in endothelial cells under hyperglycemic conditions by targeting HMGB1","volume":"88","author":"Tang","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvw235","article-title":"Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy","volume":"113","author":"Rawal","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B137","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"key":"B138","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ Res"},{"key":"B139","doi-asserted-by":"publisher","first-page":"e0147067","DOI":"10.137\/journal.pone.0147067","article-title":"MicroRNA-134 contributes to glucose-induced endothelial cell dysfunction and this effect can be reversed by far-infrared irradiation","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"B140","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/1440-1681.12227","article-title":"MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3","volume":"41","author":"Xu","year":"2014","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1161\/ATVBAHA.114.304877","article-title":"MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contribution","volume":"35","author":"Maegdefessel","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","article-title":"MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"B143","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/ATVBAHA.115.306770","article-title":"Regulation of vascular smooth muscle cell dysfunction under diabetic conditions by MIR-504","volume":"36","author":"Reddy","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.gene.2016.04.027","article-title":"MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1","volume":"586","author":"Yang","year":"2016","journal-title":"Gene"},{"key":"B145","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.2337\/db13-1015","article-title":"MicroRNA-29 finetunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes","volume":"63","author":"Kurtz","year":"2014","journal-title":"Diabetes"},{"key":"B146","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.ejphar.2016.08.038","article-title":"HNF-4\u03b1 regulated miR-122 contributes to development of gluconeogenesis and lipid metabolism disorders in type 2 diabetic mice and in palmitate treated HepG2 cells","volume":"791","author":"Wei","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1172\/JCI75438","article-title":"MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids","volume":"125","author":"Fu","year":"2015","journal-title":"J Clin Invest"},{"key":"B148","doi-asserted-by":"publisher","first-page":"494","DOI":"10.2174\/157016112800812818","article-title":"Antiplatelet therapy in patients with diabetes mellitus","volume":"10","author":"Grove","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/nsmb.1651","article-title":"Existence of a microRNA pathway in anucleate platelets","volume":"16","author":"Landry","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-1","article-title":"The complex transcriptional landscape of the anucleate human platelet","volume":"14","author":"Bray","year":"2013","journal-title":"BMC Genomics"},{"key":"B151","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1152\/physiol.00029.2015","article-title":"Exosomal miRNAs in heart disease","volume":"31","author":"Iaconetti","year":"2016","journal-title":"Physiology (Bethesda)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.diacomp.2014","article-title":"Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke","volume":"28","author":"Duan","year":"2014","journal-title":"J Diabetes Complications"},{"key":"B153","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCRESAHA.117.305784","article-title":"Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes","volume":"117","author":"Elgheznawy","year":"2015","journal-title":"Circ Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"3968206","DOI":"10.1155\/2016\/3968206","article-title":"Modulation of circulating microRNAs levels during the switch from clopidogrel to ticagrelor","volume":"2016","author":"Carino","year":"2016","journal-title":"Biomed Res Int"},{"key":"B155","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1471-4159.2005.03224.x","article-title":"Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner","volume":"94","author":"Lugli","year":"2005","journal-title":"J Neurochem"},{"key":"B156","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1160\/TH16-04-0322","article-title":"Hyperglycemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus","volume":"117","author":"Fejes","year":"2017","journal-title":"Thromb Haemost"},{"key":"B157","doi-asserted-by":"publisher","first-page":"981841","DOI":"10.1155\/2015\/98184","article-title":"The emerging role of miR-223 in platelet reactivity: implications in antiplatelet therapy","volume":"2015","author":"Shi","year":"2015","journal-title":"Biomed Res Int"},{"key":"B158","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.thromres.2013.02.015","article-title":"Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome","volume":"38","author":"Zhang","year":"2014","journal-title":"J Thromb Thrombolysis"},{"key":"B159","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00592-015-0733-0","article-title":"Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes","volume":"52","author":"Luo","year":"2015","journal-title":"Acta Diabetol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1615\/CritRevImmunol.v32.i6.10","article-title":"M1 and M2 macrophages: oracles of health and disease","volume":"32","author":"Mills","year":"2012","journal-title":"Crit Rev Immunol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2012.09.013","article-title":"Distribution of macrophage polarization markers in human atherosclerosis","volume":"225","author":"Stoger","year":"2012","journal-title":"Atherosclerosis"},{"key":"B162","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.115.308166","article-title":"MicroRNA-181b improves glucose homeostasis and insulin sensitivity by regulating endothelial function in white adipose tissue","volume":"118","author":"Sun","year":"2016","journal-title":"Circ Res"},{"key":"B163","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","article-title":"Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage","volume":"4","author":"Kuwabara","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"B164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41598-017-00070-6","article-title":"Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes","volume":"7","author":"de Golzalo-Calvo","year":"2017","journal-title":"Sci Rep"},{"key":"B165","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nat Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S0022-2828(03)00229-3","article-title":"Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells","volume":"35","author":"Shan","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1475-2840-13-44","article-title":"Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease","volume":"13","author":"Rawal","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/db16-0023","article-title":"Lack of miR-113a decreases contractility of diabetic hearts: a role for novel cross talk between tyrosine aminotransferase and tyrosine hydroxylase","volume":"65","author":"Nandi","year":"2016","journal-title":"Diabetes"},{"key":"B169","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.amjcard.2017.03.264","article-title":"Transcoronary concentration gradient of microRNA-133a and outcome in patients with coronary artery disease","volume":"120","author":"De Rosa","year":"2017","journal-title":"Am J Cardiol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1089\/scd.2011.0357","article-title":"Determination of the human cardiomyocyte mRNA and miRNA differentiation network by fine-scale profiling","volume":"21","author":"Babiarz","year":"2012","journal-title":"Stem Cells Dev"},{"key":"B171","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nm.2282","article-title":"miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin related protein-1","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"B172","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1038\/onc.2011.557","article-title":"Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis","volume":"31","author":"Palmieri","year":"2012","journal-title":"Oncogene"},{"key":"B173","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.molonc.2013.01.002","article-title":"The high mobility group A proteins contribute to thyroid transformation by regulation miR-603 and miR-10b expression","volume":"7","author":"Mussnich","year":"2013","journal-title":"Mol Oncol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jmb.2017.05.008","article-title":"miR-125a-5p modulates phenotypic switch of vascular smooth muscle cells by targeting ETS-1","volume":"429","author":"Gareri","year":"2017","journal-title":"J Mol Biol"},{"key":"B175","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1126\/science.1231776","article-title":"Epigenetic regulation by long noncoding RNAs","volume":"338","author":"Lee","year":"2012","journal-title":"Science"},{"key":"B176","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","article-title":"Long non-coding RNAs: new players in cell differentiation and development","volume":"15","author":"Fatica","year":"2014","journal-title":"Nat Rev Genet"},{"key":"B177","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","article-title":"Molecular mechanisms of long noncoding RNAs","volume":"43","author":"Wang","year":"2011","journal-title":"Mol Cell"},{"key":"B178","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"B179","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.07.012","article-title":"RNA (epi)genetics in cardiovascular diseases","volume":"89","author":"Elia","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11883-014-014-0407-3","article-title":"Noncoding RNAs and atherosclerosis","volume":"16","author":"Aryal","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"B181","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/jhg.2016.70","article-title":"Long noncoding RNA variations in cardiometabolic diseases","volume":"62","author":"Dechamethakun","year":"2017","journal-title":"J Hum Genet"},{"key":"B182","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bbacli.2015.09.001","article-title":"Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus","volume":"4","author":"Carter","year":"2015","journal-title":"BBA Clin"},{"key":"B183","doi-asserted-by":"publisher","first-page":"898","DOI":"10.7150\/ijbs.14430","article-title":"Long noncoding RNA: recent updates in atherosclerosis","volume":"12","author":"Li","year":"2017","journal-title":"Int J Biol Sci"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.114.303915","article-title":"Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure","volume":"114","author":"Kumarswamy","year":"2014","journal-title":"Circ Res"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","article-title":"Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth","volume":"114","author":"Michalik","year":"2014","journal-title":"Circ Res"},{"key":"B186","doi-asserted-by":"publisher","first-page":"e1506","DOI":"10.1038\/cddis.2014.466","article-title":"Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis"},{"key":"B187","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/jcmm.12576","article-title":"Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process in the endothelial cells","volume":"19","author":"Puthanveetil","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B188","doi-asserted-by":"publisher","first-page":"36340","DOI":"10.1038\/srep36340","article-title":"lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"B189","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.2337\/db14-0298","article-title":"Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA","volume":"63","author":"Reddy","year":"2014","journal-title":"Diabetes"},{"key":"B190","doi-asserted-by":"publisher","first-page":"e0177453","DOI":"10.1371\/journal.pone.0177453","article-title":"Long non-coding RNA Lethe regulates hyperglycemia-induced reactive oxygen species production in macrophages","volume":"12","author":"Zgheib","year":"2017","journal-title":"PLoS One"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00002\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T17:56:05Z","timestamp":1751219765000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00002\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,17]]},"references-count":190,"alternative-id":["10.3389\/fendo.2018.00002"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00002","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,17]]},"article-number":"2"}}